Loading
Inflammasome and Immune Disorders · Journal article
Frontiers in Oncology · August 12, 2026
Raises a question worth testing. It does not answer one.
This is an exploratory mechanistic study in colorectal cancer cell lines that characterizes C2orf76 as exerting context-dependent effects on chromosomal instability, pyroptosis, and chemotherapy response through gene knockout, overexpression, and rescue experiments. The work identifies molecular associations and pathways but does not establish clinical causality, therapeutic benefit, or validation in human tissue, and reports contradictory findings (e.g., favorable prognosis associations versus proliferation suppression with knockout) that require resolution.
In vitro mechanistic study with gene knockout, overexpression, and rescue cell-line models. Colorectal cancer cell lines; specific lines and eligibility criteria not stated in provided text.. Intervention: C2orf76 knockout, overexpression, and rescue in CRC cell lines. Compared with: Implicitly wild-type or control cells, but no explicit comparator arm or control group design stated..
C2orf76 knockout suppressed proliferation and migration, contradicting its favorable prognostic association. C2orf76 knockout inhibited cisplatin-induced pyroptosis and GSDME cleavage, whereas overexpression promoted migration and enhanced cisplatin sensitivity. CBMN assay confirmed C2orf76 significantly impacts chromosomal instability levels in CRC cells.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This work is preclinical and does not yet support clinical decision-making. The contradictory findings (favorable prognosis versus suppression of proliferation with knockout) and lack of in vivo or patient validation mean C2orf76 remains an exploratory target requiring mechanistic clarification and clinical translation before any therapeutic application.
Mechanistic cell-line study characterizing gene function through knockdown, overexpression, and rescue; no clinical outcomes or human validation; raises questions about C2orf76's dual roles rather than answering them in a patient context.
As stated by the source record.
Quoted from the source exactly as published.
This work is preclinical and does not yet support clinical decision-making. The contradictory findings (favorable prognosis versus suppression of proliferation with knockout) and lack of in vivo or patient validation mean C2orf76 remains an exploratory target requiring mechanistic clarification and clinical translation before any therapeutic application.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Introduction Despite advances in colorectal cancer (CRC) treatment, the chromosomal instability (CIN)-positive subgroup remains refractory to conventional therapies and immunotherapy. C2orf76, a poorly characterized gene identified as a CIN-linked candidate in CRC through bioinformatic analyses, has been associated with favorable prognosis and potential immune-related functions. However, its biological roles and underlying mechanisms in CRC remain largely unexplored. Methods To investigate the role of C2orf76, we generated knockout (KO), overexpression (OE), and rescue (RE) cell lines in CRC models. We performed RNA-seq, RT-qPCR, and Western blotting to examine transcriptomic and protein-level changes. Functional assays included proliferation, migration, cisplatin sensitivity, pyroptosis (GSDME cleavage), cytokinesis-block micronucleus assay (CBMN) for CIN, and γ-H2AX foci detection for DNA double-strand breaks. Results Unexpectedly, C2orf76 KO suppressed proliferation and migration, contradicting its favorable prognostic association and suggesting a complex regulatory role. RNA-seq revealed altered genes involved in chromosome segregation, cell cycle, platinum resistance, P53 signaling, and oncogenic pathways. RT-qPCR validated changes in chromosomal stability-related genes CDT1 and FOXM1, which were further verified by Western blotting. Further experiments showed that KO inhibited cisplatin-induced pyroptosis and cleavage of GSDME, whereas OE promoted migration and enhanced cisplatin sensitivity. The CBMN assay confirmed that C2orf76 significantly impacts chromosomal instability levels in CRC cells. C2orf76 KO cells also exhibited elevated γ-H2AX foci after cisplatin treatment. Rescue of C2orf76 expression reversed the KO-induced suppression of proliferation and migration, restored cisplatin sensitivity and pyroptosis, and reduced chromosomal instability. Discussion These findings unveil a context-dependent duality of C2orf76: knockout increases CIN, reduces proliferation and migration, but promotes chemoresistance; overexpression enhances cisplatin-induced pyroptosis and drug sensitivity yet increases migration. Thus, C2orf76 establishes a functional link between CIN, cell death, and therapeutic response, positioning it as a tunable target that may require context-dependent modulation for effective CRC intervention. This study not only characterizes a previously understudied gene but also provides a mechanistic framework for understanding how CIN-associated genes can exert opposing effects on tumor progression and treatment outcome.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.